Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients

Rationale: The current tumour-node-metastasis (TNM) staging system is insufficient for precise treatment decision-making and accurate survival prediction for patients with stage I lung adenocarcinoma (LUAD). Therefore, more reliable biomarkers are urgently needed to identify the high-risk subset in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Run, Bao, Xuanwen, Unger, Kristian, Sun, Jing, Lu, Shun, Manapov, Farkhad, Wang, Xuanbin, Belka, Claus, Li, Minglun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978303/
https://www.ncbi.nlm.nih.gov/pubmed/33754044
http://dx.doi.org/10.7150/thno.56202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978303/
https://www.ncbi.nlm.nih.gov/pubmed/33754044
http://dx.doi.org/10.7150/thno.56202

Ejemplares similares